Methanor S.C.A (ALMET) | Financial Analysis & Statements
Methanor S.C.A. | Small-cap | Utilities
Methanor S.C.A. | Small-cap | Utilities
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
79.5K
Gross Profit
79.5K
100.00%
Operating Income
-1.5M
-1,878.98%
Net Income
-714.7K
-898.96%
Balance Sheet Metrics
Total Assets
13.7M
Total Liabilities
834.2K
Shareholders Equity
12.9M
Debt to Equity
0.06
Cash Flow Metrics
Revenue & Profitability Trend
Methanor S.C.A Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 79.5K | 0 | 80.0K | 1.5K | 0 |
| Cost of Goods Sold | 0 | - | - | - | - |
| Gross Profit | 79.5K | - | - | - | - |
| Operating Expenses | 18.8K | 61.3K | -1.9M | -122.8K | -947.9K |
| Operating Income | -1.5M | -518.7K | 1.8M | -1.4M | 563.7K |
| Pre-tax Income | -714.6K | 297.4K | 1.1M | -867.0K | 313.2K |
| Income Tax | - | - | - | - | - |
| Net Income | -714.7K | 297.4K | 1.3M | -867.0K | 213.2K |
| EPS (Diluted) | - | €0.12 | €0.64 | -€0.43 | €0.11 |
Income Statement Trend
Methanor S.C.A Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 394.4K | 1.7M | 188.8K | 2.6M | 1.5M |
| Non-Current Assets | 13.3M | 11.9M | 12.2M | 8.5M | 10.7M |
| Total Assets | 13.7M | 13.6M | 12.4M | 11.2M | 12.2M |
| Liabilities | |||||
| Current Liabilities | 834.0K | 26.4K | 43.1K | 12.4K | 37.6K |
| Non-Current Liabilities | 167 | 757 | 38.1K | 101.8K | 142.8K |
| Total Liabilities | 834.2K | 27.1K | 81.2K | 114.2K | 180.4K |
| Equity | |||||
| Total Shareholders Equity | 12.9M | 13.6M | 12.3M | 11.1M | 12.1M |
Balance Sheet Composition
Methanor S.C.A Cash Flow Statement
No cash flow data available.
Methanor S.C.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
17.67
Forward P/E
12.43
Price to Book
0.53
Price to Sales
93.94
PEG Ratio
12.43
Profitability Ratios
Profit Margin
100.00%
Operating Margin
11,341.47%
Return on Equity
-5.39%
Return on Assets
-0.10%
Financial Health
Current Ratio
0.47
Debt to Equity
0.00
Beta
0.18
Per Share Data
EPS (TTM)
-€0.30
Book Value per Share
€5.35
Revenue per Share
€0.03
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| almet | 7.5M | 17.67 | 0.53 | -5.39% | 100.00% | 0.00 |
| Global Bioenergies | 1.5M | - | 0.90 | -96.88% | -59.26% | 334.06 |
| Weyerhaeuser Company | 161.4K | -0.01 | - | 554.96% | 1.71% | - |
| Engie S.A | 48.1B | 11.96 | 1.57 | 12.89% | 5.56% | 126.49 |
| Teleperformance SE | 4.7B | 8.74 | 0.99 | 11.91% | 5.09% | 108.71 |
| Orange S.A | 33.9B | 16.98 | 1.07 | 7.67% | 5.84% | 121.35 |
Financial data is updated regularly. All figures are in the company's reporting currency.